Research on the afferent transduction in the lower urinary tract

下尿路传入传导的研究

基本信息

  • 批准号:
    23390381
  • 负责人:
  • 金额:
    $ 12.31万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2011
  • 资助国家:
    日本
  • 起止时间:
    2011-04-01 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

We performed a systematic analysis of the molecular and functional expression of Piezo1 channels in the urothelium.Immunofluorescence examination demonstrated abundant expression of Piezo1 in the mouse and human urothelium. Urothelial cells isolated from mice exhibited a Piezo1-dependent increase in cytosolic Ca2+ concentrations in response to mechanical stretch stimuli, leading to potent ATP release; this response was suppressed in Piezo1- knockdown cells. In addition, Piezo1 and TRPV4 distinguished different intensities of mechanical stimulus.Moreover, GsMTx4, an inhibitor of stretch-activated channels, attenuated the Ca2+ influx into urothelial cells and decreased ATP release from them upon stretch stimulation. These results suggest that Piezo1 senses extension of the bladder urothelium, leading to production of an ATP signal. Thus, inhibition of Piezo1 might provide a promising means of treating bladder dysfunction.
我们对Piezo 1通道在尿路上皮中的分子和功能表达进行了系统的分析,免疫荧光检测显示Piezo 1在小鼠和人尿路上皮中有丰富的表达。从小鼠分离的尿路上皮细胞表现出Piezo 1依赖性增加胞浆Ca 2+浓度响应机械拉伸刺激,导致有效的ATP释放,这种反应被抑制在Piezo 1敲低细胞。此外,Piezo 1和TRPV 4还能区分不同强度的机械刺激,而牵张激活通道抑制剂GsMTx 4能抑制牵张刺激时细胞内Ca ~(2+)内流和ATP释放。这些结果表明,Piezo 1感觉膀胱尿道扩张,导致ATP信号的产生。因此,抑制Piezo 1可能提供治疗膀胱功能障碍的有希望的手段。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Intraoperative fluoroscopic monitoring during TVM surgery: safer procedure even for beginners.
TVM 手术期间的术中荧光镜监测:即使对于初学者来说也是更安全的手术。
  • DOI:
    10.4236/oju.2012.22012
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kobayashi H;Sawada N;Kira S;Miyamoto T;Haneda Y;Zakoji H;Tsuchida T;Araki I;Takeda M
  • 通讯作者:
    Takeda M
Decreased Expression of the Epithelial Ca2+ Channel TRPV5 and TRPV6 Human Cell Darinoma Associated With Vitamin D Receptor
与维生素 D 受体相关的上皮 Ca2 通道 TRPV5 和 TRPV6 人细胞 Darinoma 表达减少
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    6.6
  • 作者:
    Shin M;Mizokami A;Kim J;Ofude M;Konaka H;Kadono Y;Kitagawa Y;Miwa S;Kumaki M;Keller ET;Namiki M;Wu Yong-yang
  • 通讯作者:
    Wu Yong-yang
Connexin43 hemichannel-mediated regulation of connexin43.
Connexin43 半通道介导的 connexin43 调节。
  • DOI:
    10.1371/journal.pone.0058057
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Li K;Chi Y;Gao K;Yan Q;Matsue H;Takeda M;Kitamura M;Yao J
  • 通讯作者:
    Yao J
Clinical Efficacy and Safety of Imidafenacin as Add-on Treatment for Persistent Overactive Bladder Symptoms Despite -Blocker Treatment in Patients with BPH:
伊米达那新作为辅助治疗持续性膀胱过度活动症症状的临床疗效和安全性
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    Masayuki Takeda;Osamu Nishizawa;Momokazu Gotoh,
  • 通讯作者:
    Momokazu Gotoh,
NfKAPPAB/INOS/CAMP SIGNALING CASCADE MEDIATES INFLAMMATORY CYTOKINES-INDUCED UPREGULATION OF CONNEXIN43 EXPRESSION AND FUNCTION IN UEINARY TRACT INFECTION
NfKAPPAB/INOS/CAMP 信号级联介导炎症细胞因子诱导的泌尿道感染中 CONNEXIN43 表达和功能的上调
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yokoyama O;Hiro S;Hotta S;Mogami S;Yamagami H;Kai Li
  • 通讯作者:
    Kai Li
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKEDA Masayuki其他文献

TAKEDA Masayuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKEDA Masayuki', 18)}}的其他基金

Mechanism of driver mutation positive lung cancer
驱动突变阳性肺癌发生机制
  • 批准号:
    15K21525
  • 财政年份:
    2015
  • 资助金额:
    $ 12.31万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Studies on lower urinary tract dysfunction pathogenesis by complex systems network and dynamic homeostasis collapse
复杂系统网络和动态稳态崩溃对下尿路功能障碍发病机制的研究
  • 批准号:
    15H04972
  • 财政年份:
    2015
  • 资助金额:
    $ 12.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Research on vesicular type transporter and refractory lower urinary tract dysfunction
囊泡型转运蛋白与难治性下尿路功能障碍的研究
  • 批准号:
    26670699
  • 财政年份:
    2014
  • 资助金额:
    $ 12.31万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Mechanisms And Possible Novel Treatments for Nocturiarelated to Abnormal Circadian Rhythm
与昼夜节律异常相关的夜尿症的机制和可能的新疗法
  • 批准号:
    23659754
  • 财政年份:
    2011
  • 资助金额:
    $ 12.31万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Teaching Materials and Tools for Education of Information Science for Elementary, Junior High and High School Students
中小学生信息科学教育教材与工具
  • 批准号:
    23650515
  • 财政年份:
    2011
  • 资助金额:
    $ 12.31万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Foundational technology for light-weight XML-DBMS based on very fast compressed data stream processing
基于极快压缩数据流处理的轻量级 XML-DBMS 基础技术
  • 批准号:
    22300010
  • 财政年份:
    2010
  • 资助金额:
    $ 12.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Reseaarch on the function and development of new therapy for Ion channels in the lower urinary tract
下尿路离子通道的功能研究及新疗法的开发
  • 批准号:
    20390423
  • 财政年份:
    2008
  • 资助金额:
    $ 12.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Key Technology for XML DB in Embedded Device Based on Efficient Compressed Pattern Matching
基于高效压缩模式匹配的嵌入式XML数据库关键技术
  • 批准号:
    19300008
  • 财政年份:
    2007
  • 资助金额:
    $ 12.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of efficient machine discovery system based on data compression and pattern matching
基于数据压缩和模式匹配的高效机器发现系统的开发
  • 批准号:
    15300049
  • 财政年份:
    2003
  • 资助金额:
    $ 12.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation on mechanisms of vanilloid and cannabinoid functions in the urogenital afferent neurotransmissions
阐明香草酸和大麻素在泌尿生殖传入神经传递中的功能机制
  • 批准号:
    14370508
  • 财政年份:
    2002
  • 资助金额:
    $ 12.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Mucosal Immune Defense Mechanisms of the Urinary Bladder
膀胱粘膜免疫防御机制
  • 批准号:
    10587639
  • 财政年份:
    2023
  • 资助金额:
    $ 12.31万
  • 项目类别:
Characterization of Hypogastric Afferent Pathway Involved in Urinary Bladder Function and Dysfunction
参与膀胱功能和功能障碍的下腹传入通路的特征
  • 批准号:
    10711706
  • 财政年份:
    2023
  • 资助金额:
    $ 12.31万
  • 项目类别:
Advancing immunotherapy through cross species studies of immune cell responses and immune checkpoint inhibitor effects in dogs and humans with invasive urinary bladder cancer
通过对患有侵袭性膀胱癌的狗和人类的免疫细胞反应和免疫检查点抑制剂作用的跨物种研究来推进免疫治疗
  • 批准号:
    10651879
  • 财政年份:
    2022
  • 资助金额:
    $ 12.31万
  • 项目类别:
Mapping tissue immunity in the human urinary bladder across lifespan
绘制人类膀胱整个生命周期的组织免疫图谱
  • 批准号:
    BB/X000249/1
  • 财政年份:
    2022
  • 资助金额:
    $ 12.31万
  • 项目类别:
    Research Grant
NCI PATTERNS OF CARE (POC)/QUALITY OF CARE STUDY: DIAGNOSIS YEAR 2019 (URINARY BLADDER CANCER AND KIDNEY CANCER)
NCI 护理模式 (POC)/护理质量研究:2019 年诊断年(膀胱癌和肾癌)
  • 批准号:
    10472114
  • 财政年份:
    2021
  • 资助金额:
    $ 12.31万
  • 项目类别:
NCI PATTERNS OF CARE (POC)/QUALITY OF CARE STUDY: DIAGNOSIS YEAR 2019 (URINARY BLADDER CANCER AND KIDNEY CANCER)
NCI 护理模式 (POC)/护理质量研究:2019 年诊断年(膀胱癌和肾癌)
  • 批准号:
    10472097
  • 财政年份:
    2021
  • 资助金额:
    $ 12.31万
  • 项目类别:
NCI PATTERNS OF CARE (POC)/QUALITY OF CARE STUDY: DIAGNOSIS YEAR 2019 (URINARY BLADDER CANCER AND KIDNEY CANCER)
NCI 护理模式 (POC)/护理质量研究:2019 年诊断年(膀胱癌和肾癌)
  • 批准号:
    10472109
  • 财政年份:
    2021
  • 资助金额:
    $ 12.31万
  • 项目类别:
NCI PATTERNS OF CARE (POC)/QUALITY OF CARE STUDY: DIAGNOSIS YEAR 2019 (URINARY BLADDER CANCER AND KIDNEY CANCER)
NCI 护理模式 (POC)/护理质量研究:2019 年诊断年(膀胱癌和肾癌)
  • 批准号:
    10472104
  • 财政年份:
    2021
  • 资助金额:
    $ 12.31万
  • 项目类别:
NCI PATTERNS OF CARE (POC)/QUALITY OF CARE STUDY: DIAGNOSIS YEAR 2019 (URINARY BLADDER CANCER AND KIDNEY CANCER)
NCI 护理模式 (POC)/护理质量研究:2019 年诊断年(膀胱癌和肾癌)
  • 批准号:
    10472106
  • 财政年份:
    2021
  • 资助金额:
    $ 12.31万
  • 项目类别:
NCI PATTERNS OF CARE (POC)/QUALITY OF CARE STUDY: DIAGNOSIS YEAR 2019 (URINARY BLADDER CANCER AND KIDNEY CANCER)
NCI 护理模式 (POC)/护理质量研究:2019 年诊断年(膀胱癌和肾癌)
  • 批准号:
    10472107
  • 财政年份:
    2021
  • 资助金额:
    $ 12.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了